Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt RepaymentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization (2016 - 2021)

Tenax Therapeutics' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $564106.0 for Q4 2017.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 0.62% to $564106.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $564106.0, a 0.62% decrease, with the full-year FY2017 number at $564106.0, down 0.62% from a year prior.
  • Accumulated Depreciation & Amortization hit $564106.0 in Q4 2017 for Tenax Therapeutics, down from $573025.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for TENX hit a ceiling of $999003.0 in Q1 2013 and a floor of $564106.0 in Q4 2017.
  • Historically, Accumulated Depreciation & Amortization has averaged $679056.3 across 4 years, with a median of $589738.0 in 2016.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: dropped 24.18% in 2016 and later dropped 0.62% in 2017.
  • Tracing TENX's Accumulated Depreciation & Amortization over 4 years: stood at $828752.0 in 2013, then dropped by 9.67% to $748604.0 in 2015, then dropped by 24.18% to $567625.0 in 2016, then dropped by 0.62% to $564106.0 in 2017.
  • Business Quant data shows Accumulated Depreciation & Amortization for TENX at $564106.0 in Q4 2017, $573025.0 in Q3 2017, and $575081.0 in Q2 2017.